Roelof J Bennink
Overview
Explore the profile of Roelof J Bennink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arntz P, Olthof P, Korenblik R, Heil J, Kazemier G, van Delden O, et al.
Cardiovasc Intervent Radiol
. 2024 Feb;
47(5):642-649.
PMID: 38416177
Purpose: Sarcopenia is associated with a decreased kinetic growth rate (KGR) of the future liver remnant (FLR) after portal vein embolization (PVE). However, little is known on the increase in...
2.
Rassam F, Olthof P, Takkenberg B, Besselink M, Busch O, Erdmann J, et al.
Hepatobiliary Surg Nutr
. 2022 Aug;
11(4):530-538.
PMID: 36016749
Background: Liver regeneration is crucial to restore the functional liver mass after liver resection. The aim of this study was to evaluate the early postoperative changes in remnant liver function,...
3.
Bennink R, Prokop M, Glaudemans A, Peters-Bax L, Helthuis J, Adams A, et al.
J Nucl Med
. 2021 Jul;
PMID: 34272324
No abstract available.
4.
Madoff D, Odisio B, Schadde E, Gaba R, Bennink R, van Gulik T, et al.
Curr Oncol Rep
. 2020 May;
22(6):59.
PMID: 32415401
Purpose Of Review: For three decades, portal vein embolization (PVE) has been the "gold-standard" strategy to hypertrophy the anticipated future liver remnant (FLR) in advance of major hepatectomy. During this...
5.
Steins A, Ebbing E, Creemers A, van der Zalm A, Jibodh R, Waasdorp C, et al.
Int J Cancer
. 2019 Apr;
145(10):2792-2803.
PMID: 31018252
Multimodality treatment has advanced the outcome of esophageal adenocarcinoma (EAC), but overall survival remains poor. Therapeutic pressure activates effective resistance mechanisms and we characterized these mechanisms in response to the...
6.
Rassam F, Uz Z, van Lienden K, Ince C, Bennink R, van Gulik T
Nucl Med Commun
. 2019 Apr;
40(7):720-726.
PMID: 30998613
Objectives: Hepatobiliary scintigraphy using technetium-99m mebrofenin has been validated as a quantitative liver function test. Preoperative portal vein embolization (PVE) is performed in patients to increase future remnant liver function...
7.
van der Velden S, Braat M, Labeur T, Scholten M, van Delden O, Bennink R, et al.
J Nucl Med
. 2019 Apr;
60(10):1430-1436.
PMID: 30954942
Radioembolization is increasingly used as a bridge to resection (i.e., radiation lobectomy). It combines ipsilateral tumor control with the induction of contralateral hypertrophy to facilitate lobar resection. The aim of...
8.
Rassam F, Olthof P, Richardson H, van Gulik T, Bennink R
Nucl Med Commun
. 2019 Jan;
40(4):297-307.
PMID: 30601245
Surgical resection remains the most important curative treatment for liver tumors; however, it harbors the risk of developing posthepatectomy liver failure. The principal risk is associated with the quality and...
9.
Rassam F, Olthof P, Takkenberg B, Beuers U, Klumpen H, Bennink R, et al.
HPB (Oxford)
. 2018 Oct;
21(5):626-635.
PMID: 30366883
Background: Hepatobiliary scintigraphy (HBS) is used to quantify total and regional liver function. Transient elastography (TE) provides a non-invasive alternative to percutaneous biopsy to assess liver fibrosis and cirrhosis. This...
10.
Rassam F, Olthof P, Bennink R, van Gulik T
Visc Med
. 2018 Jan;
33(6):442-448.
PMID: 29344518
While imaging studies such as computed tomography or magnetic resonance imaging allow the volumetric assessment of the liver segments, only indirect information is provided concerning the quality of the liver...